JPRN-UMIN000008529RecruitingPhase 1
PhaseI/ II study of disulfiram in patients with advanced hepatocellular carcinoma - Phase I/II study of disulfiram in patients with advanced hepatocellular carcinoma
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
- Chiba University Hospital
- Enrollment
- 60
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 79years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1)Massive pleural or abdominal effusion 2)Uncontrolled hypertension 3)Uncontrolled heart disease 4)Evidence of Myocardial infarction witin 6 months 5)Active infection (except viral hepatitis) 6)Active gastrointestinal bleeding or ulcer 7)active double cancer 8)encephalopacy or severe mental disorder 9)severe drug allergy 10)pregnancy or lactaing females 11)inadequate for administration orally 12)Inadequate physical condition,as diagnosed by primary physician
Investigators
Similar Trials
Completed
Not Applicable
Phase 1 study of sulfapyridine in patients with advanced gastric cancer.JPRN-UMIN000010254ational Cancer Center Hospital East6
Active, not recruiting
Phase 1
Study to evaluate effectiveness of disulfiram and cisplatin in patients with refractory testicular cancer.platina refractory testicular germ cell cancerMedDRA version: 20.0 Level: PT Classification code 10061184 Term: Germ cell cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2019-000558-68-SKárodný onkologický ústav20
Active, not recruiting
Phase 1
DIsulfiram REsponse as add-on to ChemoTherapy in recurrent Glioblastoma: A randomized controlled trialGlioblastomaEUCTR2016-000167-16-SESahlgrenska University Hospital142
Active, not recruiting
Phase 1
DIsulfiram REsponse as add-on to ChemoTherapy in recurrent Glioblastoma: A randomized controlled trialMedDRA version: 19.0Level: PTClassification code 10018336Term: GlioblastomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)GlioblastomaEUCTR2016-000167-16-NOSahlgrenska University Hospital142
Completed
Phase 1
An Exploratory Study of ADR-001 in Patients with Severe Pneumonia caused by SARS-CoV-2 infection (COVID-19)Patients with Severe Pneumonia caused by SARS-CoV-2 infectionJPRN-jRCT1080225320ROHTO PHARMACEUTICAL CO., LTD.6